Shell Asset Management CO Bellus Health Inc. Transaction History

Shell Asset Management CO

  • $2.27 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 28, 2023
SELL
$0.0 - $14.75 $0 - $3,495
-237 Reduced 3.71%
6,150 $91,000
Q4 2022

Feb 07, 2023
BUY
$8.22 - $10.76 $846 - $1,108
103 Added 1.64%
6,387 $52,000
Q3 2022

Nov 14, 2022
SELL
$8.95 - $12.0 $375 - $504
-42 Reduced 0.66%
6,284 $67,000
Q2 2022

Aug 09, 2022
BUY
$6.46 - $10.02 $40,865 - $63,386
6,326 New
6,326 $58,000
Q4 2020

Feb 16, 2021
SELL
$2.27 - $3.3 $1,037 - $1,508
-457 Closed
0 $0
Q2 2020

Aug 10, 2020
BUY
$8.88 - $11.15 $4,058 - $5,095
457 New
457 $5,000

Others Institutions Holding BLU

# of Institutions
1
Shares Held
128K
Call Options Held
0
Put Options Held
0
View Full List

About BELLUS Health Inc.

BLU Quotes by TradingView
  • Ticker BLU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,793,000
  • Description
  • BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...
More about BLU
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email